Best PT-141 prescribers online
Ordered on the prescriber and the pharmacy, for a peptide approved only as one brand for one use.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.
2 sellers are partners on this board today, sorted first and labeled Partner — the one respect in which the ordering is commercial. Every other seller here is ranked purely on the published rubric, which cannot see commercial status either way.
The board at a glance
- 10 sellers are on the PT-141 board; 3 of them name their compounding pharmacy, and 1 requires a consultation before any prescription.
- The lowest monthly figure published in this board's scope is $139/mo, for PT-141 (bremelanotide) sublingual at EdgeRx; price is 6% of the order here, so it does not decide the rank.
What the evidence says, before the sellers
- PT-141 (bremelanotide)FDA-approved
Large trials for sexual health. 1 randomized trial of 1,000 or more people cited here for sexual health.
The trials measured a small average change on questionnaire scores. They cannot tell any one reader whether her desire will change enough to notice.
The ranking
Each seller below prescribes PT-141 (bremelanotide) and has a full review on this site; each block reads its care mark by mark, in the words its own pages support.
- Rank01
Synergy RxPartner
Synergy Rx is first on the PT-141 board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
PT-141 (bremelanotide) is on Synergy Rx's own list with no price we hold.
- Prescriber and intake
- Names its prescribing doctors; a consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Not recorded: no monthly price in this scope
On the PT-141 board Synergy Rx is read on 65% of the rubric's weight: dosing guidance and price against the market are left out of its order, not counted against it.
PT-141 is listed without saying whether it is Vyleesi or a compounded version. The approved product is only for low sexual desire in premenopausal women.
- Rank02
HealthRXPartner
HealthRX is second on the PT-141 board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is prescriber and intake.
- What it prices here
- PT-141 (bremelanotide) injection (compounded)from $170/mo
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
On the PT-141 board HealthRX is read on 65% of the rubric's weight: dosing guidance and state coverage are left out of its order, not counted against it.
PT-141 is an injection. The page says the brand version is approved only for premenopausal women with low desire, and that any other use is off-label. No strength is printed.
- Rank03
PlexusDx
PlexusDx is third on the PT-141 board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- PT-141 (bremelanotide) injection (compounded)from $189/mo
- Prescriber and intake
- Names its prescribing doctors
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
On the PT-141 board PlexusDx is read on 70% of the rubric's weight: dosing guidance is left out of its order, not counted against it.
PT-141 is sold as an injection taken as needed, with the dose and how often to take it set by the prescriber. The page prints no strength, and the FAQ says uncontrolled high blood pressure or a recent heart event rules it out.
- Rank04
EdgeRx
EdgeRx is fourth on the PT-141 board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- PT-141 (bremelanotide) nasal spray (compounded)from $249/mo
- PT-141 (bremelanotide) sublingual (compounded)from $139/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 46 states
- Price against the market
- At or below the market's middle
On the PT-141 board EdgeRx is read on 70% of the rubric's weight: dosing guidance is left out of its order, not counted against it.
PT-141 is sold as a 1 mg troche, eight a month, taken 30 to 60 minutes before sex, or as a 5 mg per mL spray. A tablet called Olympus pairs 1 mg of PT-141 with 20 IU of oxytocin, ten a month. No PT-141 page mentions that the brand-name drug is approved only for premenopausal women.
- Rank05
AgelessRx
AgelessRx is fifth on the PT-141 board, carried by its prescriber and intake mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- PT-141 (bremelanotide) injection (compounded)from $199/mo
- PT-141 (bremelanotide) nasal spray (compounded)from $199/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
On the PT-141 board AgelessRx is read on 65% of the rubric's weight: dosing guidance and state coverage are left out of its order, not counted against it.
PT-141 is sold as an injection or a nasal spray, used on demand at least 45 minutes before sex. The page caps use at one dose in 24 hours and eight a month, and it prints no dose. It notes that the brand version is approved only for premenopausal women.
- Rank06
June Health
June Health is sixth on the PT-141 board, carried by its prescriber and intake mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- PT-141 (bremelanotide) injection (compounded)from $179/mo
- PT-141 (bremelanotide) nasal spray (compounded)from $159/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
On the PT-141 board June Health is read on 65% of the rubric's weight: dosing guidance and state coverage are left out of its order, not counted against it.
PT-141 is an injection at $179 a month, in a 2 mg per mL or a 10 mg per mL vial, or a nasal spray at $159. The pages say to use it 30 to 60 minutes before sex. No per-dose amount is printed.
- Rank07
TeleZen MD
TeleZen MD is seventh on the PT-141 board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- PT-141 (bremelanotide) injection (compounded)from $198/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with no live visit mentioned
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
On the PT-141 board TeleZen MD is read on 65% of the rubric's weight: dosing guidance and state coverage are left out of its order, not counted against it.
PT-141 is sold to women and men as an injection, and the page mentions a nasal spray too. It prints no dose or schedule, saying only that it is not meant for daily use unless a provider directs it.
- Rank08
Bayan Health
Bayan Health is eighth on the PT-141 board, carried by its follow-up mark; its weakest mark here is stays within legal scope.
- What it prices here
- PT-141 (bremelanotide) injection (compounded)from $199/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Not recorded: our review found no answer on its pages
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists MOTS-c, BPC-157, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
On the PT-141 board Bayan Health is read on 50% of the rubric's weight: pharmacy named, dosing guidance and state coverage are left out of its order, not counted against it.
PT-141 is an injection sold as a two-month plan. The page explains that it works on the brain rather than on blood flow, but it prints no dose and does not mention the brand version's approved use.
- Rank09
YourHealthRx
YourHealthRx is ninth on the PT-141 board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is prescriber and intake.
- What it prices here
- PT-141 (bremelanotide) injection (compounded)from $209/mo
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
On the PT-141 board YourHealthRx is read on 70% of the rubric's weight: dosing guidance is left out of its order, not counted against it.
PT-141 is an injection at $209 a month. The page notes that the brand version is approved for low sexual desire in premenopausal women. No strength or schedule is printed.
- Rank10
Iron Med RX
Iron Med RX is tenth on the PT-141 board, carried by its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- PT-141 (bremelanotide) injection (compounded)from $179/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Also lists MOTS-c, BPC-157, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
On the PT-141 board Iron Med RX is read on 65% of the rubric's weight: dosing guidance and state coverage are left out of its order, not counted against it.
PT-141 is an injection at $179 a month. Its page describes the effect on desire and prints no dose, schedule or approval status. GHK-Cu is sold as a skin cream at $179 a month and as tablets at $149, with no dose or strength printed for either.
What the order on this board weighs
On the PT-141 board 7 of the rubric's 9 marks apply, rescaled to share the whole order between them: prescriber and intake carries 31%, pharmacy named carries 19% and dosing guidance carries 13%. What each mark reads
- 31%
- Prescriber and intake
- 19%
- Pharmacy named
- 13%
- Dosing guidance
- 13%
- Follow-up
- 13%
- Stays within legal scope
- 6%
- State coverage
- 6%
- Price against the market
Whether a seller pays us is not one of the 7 marks on the PT-141 board, and the rubric cannot read it.
Best PT-141 prescribers online
Frequently asked questions
- How is the PT-141 board ordered?
- The 2 partners sort first and are labeled; after that the rubric decides. The rubric reads each seller on PT-141 (bremelanotide), and here prescriber and intake carries 31%, pharmacy named carries 19% and dosing guidance carries 13%.
- Do you earn a commission from the sellers on the PT-141 board?
- On part of it. 2 sellers are partners on the PT-141 board, labeled Partner where they appear; the rest of the links pay us nothing.
- Which marks are not recorded on the PT-141 board?
- Not recorded: dosing guidance and price against the market for Synergy Rx, dosing guidance and state coverage for HealthRX, dosing guidance for PlexusDx, dosing guidance for EdgeRx, dosing guidance and state coverage for AgelessRx, dosing guidance and state coverage for June Health, dosing guidance and state coverage for TeleZen MD, pharmacy named, dosing guidance and state coverage for Bayan Health, dosing guidance for YourHealthRx and dosing guidance and state coverage for Iron Med RX. Each is left out of that seller's order on this board, because our review of its pages found no answer, and the seller's other marks carry its place instead.
- Which sellers of PT-141 (bremelanotide) are not on this board?
- 29 more sellers on our roster publish a price for PT-141 (bremelanotide) and are not ranked on the PT-141 board until we publish a review of each one.